Manage episode 304629034 series 2514197
Meet Edupression A Vienna-based App on Prescription
A friend of mine suffered from depression and committed suicide. That is what got me started with Edupression Daniel Amann, Co-Founder and CEO Edupression
Find all options to subscribe to our newsletter, podcast, YouTube channel or listen to our internet radio station here: Link https://linktr.ee/startupradio
In this interview, we talk to Daniel Amann (https://www.linkedin.com/in/daniel-amann-4a1b0711a/), the CEO and Co-Founder of Edupression (https://edupression.com/). Edupression is an anti-depression app from the greater Vienna area. Daniel has a background in financial services, where he held a lot of different positions with companies like Allianz or Raiffeisen International. One of his friends committed suicide, which drew his attention to depression.
So, he co-founded Edupression.
When you have a depressive episode, there is a 50% probability, that you will have another depressive episode. Daniel Amann, Co-Founder and CEO Edupression
Want to be found by Business opportunities or contacted by new investors?
Get scouted by us, when we have a matching mandate and enroll your startup in our database: https://forms.gle/DmPtBKJH7MMmJoYo8
We don’t sell your data or spam you. We will even reach out to you before we include you in a scouting mandate.
In total the founding team of Edupression (https://edupression.com/) are 4 co-founders, which spent approx. three years working on Edupression before the interview, including advice from the Medical University Vienna (https://en.wikipedia.org/wiki/MedicalUniversityof_Vienna).
Edupression is a certified medical product, as a stand alone therapy for mild to medium depression symptoms, stand alone or in combination with drugs or psychotherapy. The company plans to have the app available on prescription in January 2022 in Germany and Austria.
In the German-speaking area (Germany, Switzerland, Austria) there are approx. 8 million people suffering from depression. … It is also the same in the US, Canada or developing countries, around 7-8%. Daniel Amann, Co-Founder and CEO Edupression
Apple’s App Store (https://apps.apple.com/app/id1562982041)
There are a number of different depression questionnaires that can be used. The PHQ-9 patient questionnaire is effective, as it not only evaluates the severity of depression, but also identifies whether a patient is actually suffering from depression in the first place. You can find the questionnaire here https://edupression.com/phq-test-complete/
We also want to expand internationally, we are looking at the US expansion for the end of 2022. Daniel Amann, Co-Founder and CEO Edupression
Venture Capital Funding
Edupression is currently looking to raise a Series A funding for their international expansion in 2022. They would like to close the round end of 2021 or early in 2022.
Find all links and show notes here: https://www.startuprad.io/blog/meet-edupression-a-vienna-based-app-on-prescription/